XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net loss $ (166,637) $ (127,363)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 409 407
Stock-based compensation 11,962 11,128
Amortization of debt-related costs 1,444 1,156
Accretion of marketable securities purchased at a discount (7,418) (3,613)
Other non-cash adjustments 481 0
Changes in operating assets and liabilities:    
Increase in accounts receivable (1,885) (290)
Increase in inventories (255) (336)
Increase in prepaid expenses and other current assets (1,576) (1,935)
Decrease in other long-term assets 513 389
Increase in accounts payable and other liabilities 5,673 9,108
Net cash used in operating activities (157,289) (111,349)
Cash flows from investing activities:    
Purchases of property and equipment (557) (470)
Purchases of investments (302,921) (223,241)
Maturities of investments 234,400 121,870
Net cash used in investing activities (69,078) (101,841)
Cash flows from financing activities:    
Proceeds from issuance of common stock for equity incentive plans 89 0
Proceeds from issuance of common stock, net of fees 0 138,823
Proceeds from issuance of preferred stock, net of fees 241,400 0
Repurchase of common stock for equity incentive plans (1,730) (824)
Proceeds from debt borrowings, net of fees 0 49,962
Other debt financing fees (1,306) 0
Net cash provided by financing activities 238,453 187,961
Net increase (decrease) in cash and cash equivalents 12,086 (25,229)
Cash and cash equivalents at beginning of period 22,465 46,345
Cash and cash equivalents at end of period 34,551 21,116
Supplemental disclosure of cash flow information:    
Cash paid for interest 9,794 6,767
Supplemental disclosure of non-cash investing and financing activities:    
Conversion of preferred stock to common stock 115 0
Issuance of equity-classified warrants $ 0 $ 307